Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Heraeus Medical and OrthoCyte agree to develop stem cell based bone graft product

Oct. 2, 2015

Bone Therapeutics initiates trial of ALLOB for minimally invasive revision spinal surgery

Oct. 1, 2015

Topline results from third phase III trial of baricitinib for rheumatoid arthritis

Sep. 30, 2015

AbbVie passes on Galapagos' filgotinib, plans to advance own JAK1 inhibitor to phase III

Sep. 29, 2015

Eisai discovers inhibitor of interaction between TRAF6 and TNF superfamily receptors

Sep. 25, 2015

RuiYi initiates first human dosing of gerilimzumab

Sep. 23, 2015

AB Science stops phase III study of masitinib in rheumatoid arthritis

Sep. 23, 2015

Rat forelimb allotransplantation model enables assessment of function

Sep. 22, 2015

Corbus initiates phase II trial of Resunab for systemic sclerosis

Sep. 3, 2015

FDA approves Augment Bone Graft

Sep. 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...